Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects

• Published in: Journal of immunological methods Vol. 500; p. 113197
• Main Authors: Manenti, Alessandro, Gianchecchi, Elena, Dapporto, Francesca, Leonardi, Margherita, Cantaloni, Paolo, Fattorini, Filippo, Piu, Pietro, Bollati, Valentina, Pastorino, Ugo, Apolone, Giovanni, Sozzi, Gabriella, Montomoli, Emanuele
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.01.2022; The Authors. Published by Elsevier B.V
• Subjects: Anti-S antibodies; Antibodies, Neutralizing - immunology; Antibodies, Neutralizing - metabolism; Antibodies, Viral - immunology; Antibodies, Viral - metabolism; China; Convalescence; COVID-19 - diagnosis; COVID-19 - immunology; COVID-19 Serological Testing - methods; COVID-19 Vaccines - immunology; human population; Humans; humoral immunity; Immunization, Secondary; neutralization; Neutralizing antibodies; Protein Binding; regression analysis; SARS Virus - physiology; SARS-CoV-2; SARS-CoV-2 - genetics; SARS-CoV-2 vaccine; Severe acute respiratory syndrome coronavirus 2; Technical Note; Vaccination; China; Anti-S antibodies; SARS-CoV-2 vaccine; SARS-CoV-2; Neutralizing antibodies
• ISSN: 0022-1759; 1872-7905; 1872-7905
• DOI: 10.1016/j.jim.2021.113197

Since the first detection of a novel Coronavirus (SARS-CoV-2) in December 2019 in Wuhan (China), it has become crucial to assess and quantize the human humoral immune response after SARS-CoV-2 natural infection and/or vaccination. Having well standardized and reliable serological assays able to accurately measure the total IgG antibodies response as well as the neutralization dynamics, play a pivotal role for the evaluation of “second” and “third” vaccines generation and in monitoring the effect in case of reinfection in the human population caused by the original strains or new SARS-CoV-2 variants. In the present study we reported that both symptomatic convalescent and vaccinated donors showed the presence of different levels of neutralizing antibodies. In addition, vaccinated subjects presented high levels of anti-S antibodies, whereas the complete absence of anti-N antibodies, whereas convalescent patients presented high levels of both anti-S and anti-N antibodies. The evaluation of the correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects revealed that the IgG anti-S log-values were significantly higher in the vaccinated group respect to convalescent subjects. In addition, the level of binding antibodies recognizing the S protein shows a positive linear regression when compared to neutralizing titres in both the two groups evaluated.